Prestige Consumer Healthcare vs Trulieve Cannabis
Prestige Consumer Healthcare and Trulieve Cannabis are similar in size: $1.09bn and $1.18bn of revenue in their latest fiscal years. Trulieve Cannabis grew faster (-0.4% against -4.3%). Prestige Consumer Healthcare kept more of each dollar of sales as profit: a net margin of 17.5% against -9.9%.
| Latest fiscal year | Prestige Consumer HealthcarePBH, 2026 | Trulieve CannabisTRLV, 2025 |
|---|---|---|
| Revenue | $1.09bn | $1.18bn |
| Revenue growth | -4.3% | -0.4% |
| Net income | $190m | −$116m |
| Operating margin | — | 12.1% |
| Net margin | 17.5% | -9.9% |
| Return on equity | 10.2% | -9.7% |
| Free cash flow | $246m | $229m |
| Cash | $63.9m | $256m |
| Total debt | $1.00bn | $141m |
| Debt to equity | — | 12.3% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $156m | — |
| Employees | 890 | 5,000 |
| Market value | $2.34bn | $2.20bn |
| Price vs our value range | Within our value range | Below our value range |
| Moat score | 67 (Moderate) | 28 (Weak) |
| Insider trades, 12 months | 0 buys, 8 sales | 0 buys, 7 sales |